Using 2PEM and a FRET biosensor for ERK, Hirata et al. showed that a BRAF inhibitor activates ERK in melanoma‐associated fibroblasts by a mechanism known as ‘paradoxical activation’, and that the activated fibroblasts provide a “safe haven” for melanoma cells to tolerate BRAF inhibition.96 Here, BRAF is linked to melanoma.